Emmanuel Frempong-Manso is an Infectious Disease physician. OpenAlex indexes 5 publications with 299 citations (h-index 4).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
117 Fox Plan Rd Ste 104
Monroeville, PA 151462723
Telephone
412-896-4248Provider last certified this registry record 29 Oct 2025.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Inari Medical, Inc.Program year20232 payments
- Cumberland Pharmaceuticals, Inc.Program year20232 payments
- Gilead Sciences, Inc.Program year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
89.8%Penicillins with extended spectrum20.9%Piperacillin-Tazobactam59%Amoxicillin27%Amoxicillin-Clavulanate Potass14%Part D≥19 patientsTetracycline-class Drug13.8%Doxycycline Hyclate100%Part D≥48 patients+ 10 more classes in this area
Sensory organs
10.2%Aminoglycoside Antibacterial6.7%Gentamicin Sulfate100%Part D≥15 patientsFluoroquinolone Antibacterial3.5%Ciprofloxacin Hcl100%Part D≥11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Analyses of Multidrug Efflux Pump-Like Proteins Encoded on the Staphylococcus aureus Chromosome
Antimicrobial Agents and Chemotherapy
2014 - In silico genetic correlations of multidrug efflux pump gene expression in Staphylococcus aureus
International Journal of Antimicrobial Agents
2010 - Abacavir/lamivudine combination in the treatment of HIV: a review
DOAJ (DOAJ: Directory of Open Access Journals)
2010 - Inability of a reserpine-based screen to identify strains overexpressing efflux pump genes in clinical isolates of Staphylococcus aureus
International Journal of Antimicrobial Agents
2008 - Efflux-Related Resistance to Norfloxacin, Dyes, and Biocides in Bloodstream Isolates of<i>Staphylococcus aureus</i>
Antimicrobial Agents and Chemotherapy
2007
Similar KOLs
Other experts from the same institution or the same specialty.
Yousef Khader
Jordan University of Science and Technology
Andrew Rambaut
University of Edinburgh
Olayinka Stephen Ilesanmi
University College Hospital
Maysaa El Sayed Zaki
Mansoura University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”